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The results of meniscal allograft
transplantation surgery: what is success?
Henry Searle1, Vipin Asopa2, Simon Coleman3 and Ian McDermott2*
Abstract
Background: Meniscal allograft transplantation (MAT) may improve symptoms and function, and may limit
premature knee degeneration in patients with symptomatic meniscal loss. The aim of this retrospective study was
to examine patient outcomes after MAT and to explore the different potential definitions of ‘success’ and ‘failure’.
Methods: Sixty patients who underwent MAT between 2008 and 2014, aged 18–50 were identified. Six validated
outcome measures for knee pathologies, patient satisfaction and return to sport were incorporated into a
questionnaire. Surgical failure (removal of most/all the graft, revision MAT or conversion to arthroplasty), clinical
failure (Lysholm < 65), complication rates (surgical failure plus repeat arthroscopy for secondary allograft tears) and
whether patients would have the procedure again were recorded. Statistics analysis included descriptive statistics,
with patient-reported outcome measures reported as median and range. A binomial logistic regression was
performed to assess factors contributing to failure.
Results: Forty-three patients (72%) responded, mean age 35.6 (±7.5). 72% required concomitant procedures, and
44% had Outerbridge III or IV chondral damage. The complication rate was 21% (9). At mean follow-up of 3.4 (±1.6)
years, 9% (4) were surgical failures and 21% (9) were clinical failures. Half of those patients considered a failure
stated they would undergo MAT again. In the 74% (32) reporting they would undergo MAT again, median KOOS,
IKDC and Lysholm scores were 82.1, 62.1 and 88, compared to 62.2, 48.5 and 64 in patients who said they would
not. None of the risk factors significantly contributed to surgical or clinical failure, although female gender and
number of concomitant procedures were nearly significant. Following MAT, 40% were dissatisfied with type/level of
sport achieved, but only 14% would not consider MAT again.
Conclusions: None of the risk factors examined were linked to surgical or clinical failure. Whilst less favourable
outcomes are seen with Outerbridge Grade IV, these patients should not be excluded from potential MAT. Inability
to return to sport is not associated with failure since 73% of these patients would undergo MAT again. The disparity
between ‘clinical failure’ and ‘surgical failure’ outcomes means these terms may need re-defining using a specific/
bespoke MAT scoring system.
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Background
The menisci act primarily as load bearers and secondary
stabilisers within the knee joint, and are chondroprotective.
Loss of meniscal tissue through trauma or degeneration in-
creases the joint contact forces by up to 350%, exacerbating
articular cartilage degeneration [1]. Meniscal tears are par-
ticularly common in sportspersons [2, 3] with the typical
mechanism of injury involving twisting on a flexed knee or
loaded hyperflexion [4]. Symptomatic meniscal tears may
require repair, or, if irreparable, a partial meniscectomy [5],
significantly increasing the risk of future chondral failure
and, ultimately, secondary osteoarthritis [6].
Meniscal Allograft Transplantation (MAT) was first
reported in 1989, and is a useful potential option for
symptomatic patients where there is loss or discontinuity
of the peripheral meniscus and where the degenerative
damage is not yet severe enough or the patient is too
young for artificial joint replacement surgery to be a
suitable option [7–9]. However, MAT is a technically de-
manding procedure, performed by only a small number
of surgeons, and graft availability and cost can be prob-
lematic [10]. Patients eligible for MAT are typically
young and high-demand, and they are a highly-complex
population who have often already endured multiple
previous surgical procedures, and many have expecta-
tions to return to high activity levels [1]. Although a
challenge, restoring function in this patient population is
a priority within orthopaedics today [11].
Whilst outcome data is limited by low volumes and
short follow-up, there is evidence that MAT can relieve
pain, optimising knee function and comfort in selected pa-
tients [7]. A pilot randomised-controlled trial in 2018 con-
firmed MAT had better outcomes at 1 year compared to
physiotherapy [12]. Authors have reported positive patient
outcome measures following MAT using the KOOS,
IKDC, Lysholm, Tegner, and SF-12 scores [13–16]. It re-
mains unclear what proportion of any improvement might
be due to MAT alone or from potential concomitant pro-
cedures [17], and it is also unclear whether MAT has any
long-term chondroprotective effect [18]. Whilst many
studies have found that the addition of concomitant pro-
cedures at the same time as MAT do not affect outcomes,
a recent study showed that compared to isolated MAT,
PROMs were improved by the addition of a high tibial
osteotomy to offload the affected compartment [19]. Cer-
tainly, MAT has been shown to have a higher-failure rate
in ACL-deficient knees [20].
Surgical failure is defined variably in studies, but is
most often defined as the patient either requiring re-
moval of the allograft, allograft revision or conversion to
joint replacement (arthroplasty) [13]. Clinical failure is
often defined as a Lysholm Score of < 65 and has been
shown not to correlate well with surgical failure or poor
patient-reported outcomes [13].
There are differing definitions of failure within the
existing literature, with surgical failure not necessarily
correlating to clinical failure. The aim of this study was
to examine the outcomes of MAT in one surgeon’s
patient cohort (using the same graft preparation and fix-
ation techniques), using a variety of surgical and patient-
reported outcome measures, with a view to exploring
the question of what ‘success’ might actually mean. As
with most studies of MAT, many patients required add-
itional concomitant procedures alongside MAT, compli-
cating the assessment of outcomes. It was hypothesized
that patients classified as ‘surgical failures’ or ‘clinical
failures’ would have significantly lower outcome mea-
sures compared to those who were not.
Methods
Ethical and Risk Assessment Approval was obtained from
the University of Edinburgh’s Moray House School of Edu-
cation, and use of the surgeon’s data was approved by The
London Bridge Hospital Clinical Governance Committee,
and information governance was maintained throughout
the study.
Following informed consent, a retrospective analysis of
patients aged 18 to 50 years who had undergone MAT
by a single surgeon between 2008 and 2014 was under-
taken. The indications for MAT were symptomatic pa-
tients with complete or subtotal loss of a meniscus
causing pain and reduced function, with evidence of
post-meniscectomy degenerative damage where artificial
joint replacement surgery was not yet indicated. Each
patient had previously been assessed for suitability for
MAT by history, clinical examination, imaging and
arthroscopic findings, with the principles of treatment
fully explained. Alignment and stability were assessed
before MAT, to check whether concomitant procedures
were also required. Table 1 shows the list of the 31 con-
comitant procedures performed, with anterior cruciate
ligament (ACL) reconstruction being the most common.
Sixty patients were identified and sent questionnaires,
with zero excluded.
Table 1 List of Concomitant Procedures
Concomitant Procedure Number
+ Microfracture 4
+ Chondrotissue cartilage grafting 5
+ ACL reconstruction 14
+Microfracture 1
+ Chondrotissue cartilage grafting 2
+ PCL reconstruction + Chondrotissue cartilage grafting 1
+ Tibial realignment osteotomy 2
+ Chondrotissue cartilage grafting 2
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Surgical procedure
All grafts were fresh-frozen, non-irradiated BioCleansed®
menisici obtained from RTI Surgical, Inc., Florida. The
grafts were size-matched using the Pollard technique
[21, 22] and fixed arthroscopically using transosseuous
tibial bone tunnel suture fixation for the anterior and
posterior insertional ligaments, plus peripheral capsular
sutures, using the method described by Matava et al.
[23]. This is considered by many to be the most practical
way to secure fixation of the graft [24].
Rehabilitation
Following surgery, patients were advised to use crutches
and a hinged knee brace locked at 0° to 90° for the first
6 weeks. Rehabilitation was then commenced to regain
full range-of-motion, with proprioceptive reflex re-
training, with slow and cautious muscle strengthening
exercises, progressing to light non-impact cardiovascular
fitness exercises. Patients were specifically advised to
avoid loaded deep knee flexion, heavy weights, loaded
twisting or impact through the knee. Patients were spe-
cifically advised against returning to any impact type ex-
ercise/sport [11].
Clinical assessment and questionnaire
A request to complete an online self-administered ques-
tionnaire was sent via email in December 2016 using
QuestionPro software. The date of follow-up was the date
the patient completed the online questionnaire. Validated
patient-reported outcome measures (PROMs) for knee
pathologies (IKDC, KOOS, Tegner and Lysholm) were in-
corporated into the questionnaire [25]. A Visual Analogue
Score (VAS) pain score (0 to 10) and SF-12 Short-Form
Health Survey were also used. The SF-12 was also split in
the ‘mental’ and ‘physical’ subscales, which were analysed
separately. Where questions from the IKDC and KOOS
asked about specific joint-loading activities that the pa-
tients had specifically been advised not to perform, a ‘Not
Applicable’ option was added. Questions on sport were in-
cluded in the questionnaire, despite the surgeon having
specifically advised all patients against ever returning to
impact or twisting type activities. Patients were also asked
whether they would have the procedure again.
Surgical failure was gathered from clinical documenta-
tion, and was defined as removal of most or all of the
allograft, allograft revision or conversion to joint arthro-
plasty. ‘Clinical failure’ was defined as a Lysholm score
of < 65. Time from MAT surgery to surgical failure was
noted. Time to clinical failure was defined as being from
the date of MAT surgery to the date of the patient com-
pleting the questionnaire. As there was no continual
follow-up, it is acknowledged that clinical failure may
have occurred prior to the study’s follow-up. The com-
plication rate for MAT surgery was defined as including
those patients who underwent repeat arthroscopy for
secondary allograft tears as well as those patients who
were surgical failures.
Statistical analysis
The results were analysed, with descriptive statistics and
with PROMs reported as median and range.
Comparisons between PROMs from patients with versus
without surgical failure, and with versus without clinical
failure were carried out. Data were checked for normality
using Shapiro-Wilk tests (Field [26]) with α-level set at 0.05,
and if data were normally distributed then independent t-
tests (α =0.05) were carried out. If data were non-normal,
Mann-Whitney U non-parametric tests were performed. Ef-
fect sizes were also calculated and classified according to
Cohen [27] [30]; small (0.2), medium (0.5), large (0.8).
PROMS were also compared between patient groups on
whether or not they would have the procedure again (Yes /
No / Not sure) using One-Way ANOVA (α =0.05) or
Kruskal-Wallis tests, depending on whether data were nor-
mal or not. Effect sizes were assessed with Partial Eta
Squared with small, medium and large being 0.01, 0.06,
0.14 respectively [26]. The difference between pre- and
post-operative Tegner scores was analysed using a repeated
measures t-test if the data were normally distributed, and a
Wilcoxon matched Pairs Signed Ranks test if they were not.
Relationships between five previously studied risk fac-
tors (age, gender, number of concomitant procedures,
Outerbridge grade, lateral vs medial side of MAT) and
surgical and clinical failures were examined with binary
multiple logistic regression forced entry method (BMLR)
with α =0.05 [26].
Results
Of the total of 60 MAT procedures performed on 60 pa-
tients by this surgeon during the period 2008–2014, 43
(72%) patients responded, with a mean follow-up of 3.4 (±
1.6) years. Seventeen patients (28%) did not respond.
Table 2 outlines the baseline demographics of the patients.
Data were not normally distributed for all the PROMs
except the IKDC and VAS scores. Therefore Table 3
shows the median and interquartile PROM scores for the
whole cohort and for the surgical failure and clinical fail-
ure groups. For 3 patients, their responses to the IKDC
were < 90% complete, rendering them invalid, and these
were therefore excluded. All KOOS scores were valid.
The complication rate was 21%. Four patients were
classified as surgical failures and nine were classed as
clinical failures, with three patients having both surgical
and clinical failure. The mean times to surgical and clin-
ical failures were 1.8 and 2.6 years respectively. Statistical
comparison tests did not show any significant differences
for any of the PROMs between the two groups. How-
ever, Effect Sizes for KOOS and Lysholm scores were
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large. The Effect Sizes for IKDC, post-operative Tegner
scores and SF-12 mental subscale were medium-large
and SF-12 (whole test) was small-medium. There was no
effect between the two surgical failure groups for pre-
operative Tegner Activity Scale. For clinical failure, there
were significant differences (p < 0.001) between groups
for KOOS and Lysholm scores, for the IKDC, the VAS
and the post-operative Tegner values (all p = 0.002), for
the SF-12 (p = 0.041) and SF-12 physical subscale (p =
0.024) but not for pre-operative Tegner. Effect Sizes for
all PROMs were large, except for pre-operative Tegner
score, which was small-medium. The Wilcoxon test
showed that there was a significant difference (p < 0.001)
between pre- and post-operative Tegner scores for the
whole sample, and this also had a large effect size.
Six patients stated that they would not have the pro-
cedure again, with two of these being clinical failures,
one being a surgical failure and clinical failure, but three
of these did not come under either of the definite failure
categories. Five patients were unsure whether they
would repeat the procedure again, with the remaining 32
stating they would undergo it again. Table 4 shows the
PROM scores grouped by patients’ statements about
whether or not they would undergo the procedure again
(Yes / No / Not Sure). There were no statistical differ-
ences between the groups, although the KOOS (p =
0.091), SF-12 physical subscale (p = 0.085) and Lysholm
scores (p = 0.056) approached significance. Effect sizes
between the groups were large for KOOS and Lysholm
values, medium-large for the SF-12 physical subscale
and small-medium for all other PROMs.
Full results for the BMLRs are shown in Tables 5 and 6.
The regression found none of the five risk factors was sig-
nificantly related to the chance of surgical failure, although
gender (being female) was nearly significant (p = 0.064). In
the regression for clinical failure, again, none of the risk
factors was significant, although gender (p = 0.077) and
number of concomitant procedures (p = 0.067) were
nearly significantly linked to the chance of clinical failure.
Pre-operative and post-operative patient sporting ac-
tivity, using a combination of findings from experimental
studies and clinical investigations to define intensity of
impact [28], is shown in Table 7. Thirty two (74%) pa-
tients returned to fewer, lower intensity sporting activ-
ities following MAT, with 34 patients (79%) expecting
this change. Of those who did not return to the same
level of sport, 73% stated that they would undergo the
procedure again. At review, 39.2% were satisfied, 20.9%
Table 3 Median (Interquartile Range) Patient-Reported Outcome Measures (PROMs) for whole sample, surgical and clinical failure
groups
PROM Sample
(n = 43)
Surgical Failure Yes
(n = 4)
Surgical Failure No
(n = 39)
Clinical Failure Yes
(n = 9)
Clinical
Failure No
(n = 34)
KOOS 80.0 (24.4) 66.6 (38.1) 81.0 (24.3) 58.3 (19.4) 82.1 (14.1) ***
IKDC a 55.8 (29.3) 46.6 (37.1) 59.8 (29.3) 43.0 (17.3) 64.4 (26.5) **
VAS 3.0 (3.0) 4.5 (3.0) 3.0 (2.0) 5.0 (3.0) 3.0 (2.0) **
Tegner pre-operative 7.0 (3.0) 7.0 (4.0) 7.0 (3.0) 6.0 (3.0) 7.0 (3.0)
Tegner post-operative 4.0 (3.0) 2.5 (4.0) 4.0 (3.0) 2.0 (2.0) 5.0 (2.0) **
SF-12 40.0 (7.0) 39.5 (19.0) 40.0 (7.0) 35.0 (16.0) 40.0 (7.0) *
SF-12 Mental 22.0 (4.0) 21.5 (10) 22.0 (4.0) 21.0 (10.0) 22.0 (4.0)
SF-12 Physical 17.0 (4.0) 17.0 (4.0) 18.0 (9.0) 14.0 (5.0) 18.0 (4.0) *
Lysholm 81.0 (25.0) 59.5 (54.0) 81.0 (23.0) 51.0 (26.0) 88.0 (18.0) ***
a IKDC responses incomplete for three patients so sample numbers reduced to (40,4,36,9,31).
* - significant at p < 0.05
** - significant at p < 0.01
*** - significant at p < 0.001
Table 2 Baseline Demographics
Characteristic Total
Number of Meniscal Allograft Transplants 43
Lateral/Medial 16/27
Male/Female 31/12
Mean Age in years (±SD) 35.6 (±7.5)
Number of concomitant procedures
0 12
1 21
2 7
3 3
Outerbridge cartilage grade
0 2
1 3
2 21
3 1
4 16
Mean time to follow up in years (±SD) 3.4 (±1.7)
Searle et al. BMC Musculoskeletal Disorders          (2020) 21:159 Page 4 of 9
were neither satisfied nor dissatisfied, and 40% were dis-
satisfied with their level of sporting activity achieved fol-
lowing surgery.
Discussion
This study sought to record the PROMs of patients who
had undergone MAT, and to investigate whether there
were differences reported in those patients with ‘surgical
failure’ or ‘clinical failure’ versus those categorised as be-
ing ‘successful’.
For the whole sample, PROM scores showed generally
good outcomes, with median KOOS, IKDC and Lysholm
scores being 80, 55.8 and 81. Further investigation
showed that there was a trend towards PROMs being
lower in those patients with surgical failure, although
this was not statistically significant. This was possibly
due to the small sample of surgical failures (n = 4). Pa-
tients classified as clinical failures did have significantly
lower KOOS and IKDC scores, and lower post-operative
Tegner values. In the present study, 74% of patients said
that they would undergo MAT again. The median post-
operative Lysholm, KOOS and IKDC scores in this sub-
group were 88, 82, and 62.1 - scores consistent with
good outcomes following MAT. However, there were no
significant differences in PROMs between those who
stated that they would undergo the procedure again
compared to those who stated that they would not and
those who were not sure.
The results for Lysholm, KOOS and Tegner scores
compared favourably or similarly to other reported series
in the published literature [14–16], although our IKDC
scores were lower [15]. Naimark et al. reported similar
outcomes in patients who underwent arthroscopic par-
tial meniscectomy [29]. The Tegner scores were signifi-
cantly reduced following surgery, probably due to the
specific post-operative restrictions that were recom-
mended by the operating surgeon.
It should be noted that there are other techniques to re-
place menisci, such as the Actifit and the Collagen Meniscal
Implant. Interestingly, the studies evaluating the effect of
these treatments also do not have a consensus on accepted
definitions of failures [30]. However, these implants are
only suitable specifically for the treatment of partial menis-
cal loss where the is still continuity of the peripheral menis-
cal rim, as they require a meniscal rim for attachment [31].
This therefore makes comparison to MAT difficult. De
Coninck et al. reported more favourable outcomes in IKDC
with the Actifit compared to our study, but our study
showed higher results in KOOS and Lysholm scores [32].
The two studies had comparable mean ages, but De Con-
inck excluded patients who had severe cartilage damage,
whilst in our study 44% had an Outerbridge Grade III or
IV, and this may explain the higher IKDC scores in their
study. Furthermore, the KOOS and IKDC scores both con-
tain questions regarding activities such as jumping, twisting
and pivoting; activities which our participants were advised
not to undertake, and so may bias results, as other studies
also report higher scores in these questionnaires [33, 34].
While the number of patients undergoing MAT remains
small, finding the right tool to evaluate patients is prob-
lematic. New scoring systems may provide improved
evaluation of MAT.
The Western Ontario Meniscal Evaluation Tool
(WOMET) may be appropriate. It is a specific question-
naire aimed to detect the impact of meniscal tears on
health-related quality of life [35]. When first designing this
present study, it was decided not to include WOMET as
there were doubts at that time with regard to WOMET’s
reliability, construct validity and responsiveness [36]. It
would also have caused questionnaire fatigue by adding a
Table 4 Median (Interquartile Range) Patient-Reported
Outcome Measures (PROMs) against whether patients would
have the procedure again
PROM Yes
(n = 32)
No
(n = 6)
Not Sure
(n = 5)
KOOS 82.1 (21.4) 62.2 (39.5) 79.8 (20.2)
IKDC a 62.1 (28.2) 48.5 (40.8) 49.4 (19.6)
VAS 3.0 (2.0) 4.5 (4.0) 3.0 (3.0)
Tegner pre-operative 7.0 (3.0) 6.0 (1.0) 6.0 (4.0)
Tegner post-operative 4.0 (3.0) 3.5 (3.0) 2.0 (4.0)
SF-12 40.0 (8.0) 38.5 (18.0) 37.0 (6.0)
SF-12 Mental 22.0 (4.0) 22.0 (12.0) 23.0 (4.0)
SF-12 Physical 18.0 (4.0) 16.0 (6.0) 15.0 (3.0)
Lysholm 88.0 (25.0) 64.0 (48.0) 73.0 (16.0)
a IKDC responses incomplete for three patients so sample numbers reduced
to (29,6,5).
Table 5 Binomial logistic regression for surgical failure
Variable b Standard Error Wald p-value Exp(B)
Age 0.022 0.078 0.081 0.776 1.023
Gender 2.506 1.352 3.434 0.064 12.260
No. of concomitant procedures 0.596 0.927 0.414 0.520 1.815
Outerbridge grade 0.167 0.730 0.053 0.819 1.182
Lateral vs medial −0.064 1.551 0.002 0.967 0.938
Constant −5.449 3.618 2.269 0.132 0.004
Searle et al. BMC Musculoskeletal Disorders          (2020) 21:159 Page 5 of 9
raft of further questions which may have reduced question-
naire completion rates. Whilst Sgroi et al. reported super-
ior measurement of knee function and quality-of-life
impairment using WOMET compared to the KOOS in
patients treated for meniscal tears [37], to the authors’
knowledge, it had not been used in studies purely investi-
gating MAT. Whether WOMET is indeed a more useful
tool for the evaluation of patients who have undergone
MAT, however, is a topic in itself for further research.
Until the most appropriate and validated scoring system is
established for the evaluation of patients who have under-
gone MAT, this present study suggests that success cannot
be adequately defined.
The surgical failure rate of 9% was similar to that re-
ported in other comparable studies, which have reported a
failure rate of 10.4% [13]. The clinical failure rate of 21%
was greater than that reported by Lee et al. [16] (8.5%)
and Zaffagnini et al. [14], (11%). The complication rate
was 21%; similar to the 21.3% rate reported in the meta-
analysis by El Attar et al. [7]. A consensus regarding the
Table 6 Binomial logistic regression for clinical failure
Variable b Standard Error Wald p-value Exp(B)
Age 0.076 0.065 1.365 0.243 1.079
Gender 1.843 1.042 3.130 0.077 6.314
No. of concomitant procedures 1.299 0.709 3.355 0.067 3.665
Outerbridge grade 0.131 0.490 0.072 0.789 1.140
Lateral vs medial 1.056 1.069 0.976 0.323 2.876
Constant −7.144 3.269 4.776 0.029 0.001
Table 7 Sporting activities undertaken before and after MAT
Sports Category Sport Percentage
playing
before MAT
Percentage
playing
after MAT
Category of joint
loading
Ball Sports Soccer 8% High
Rugby 7% High
Golf 6% 10% Low
Cricket 5% Medium
Field Hockey 2% High
Netball 2% High
Lacrosse 1% High
Basketball 1% High
Volleyball 1% High
Ultimate Frisbee 1% High
Racquet Sports Tennis 7% 4% High
Squash 3% High
Badminton 2% High
Adventure Sports Rock Climbing 2% Medium
Paragliding 1% Medium
Motocross 1% High
Combat Sports Tae-kwon do 1% High
Boxing 1% 2% Medium
Snowsports Skiing 11% 4% Low
Aerobic Sports Running 11% High
Walking 5% 17% Low
Roller-blading 2% High
Watersports Swimming 6% 15% Low
Waterskiing 6% High
Cycling Road Cycling 12% 42% Medium
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current definition of clinical and surgical failure is re-
quired, since two (50%) patients with surgical failures and
six (66.7%) with clinical failures said that they would
undergo the MAT procedure again or were unsure. It is
concerning that previous authors have solely used these
endpoints to report the efficacy of MAT.
This study, therefore, suggests that the term ‘patient
satisfaction’ may define success better than ‘surgical fail-
ure’ or ‘clinical failure’. Patient satisfaction, in terms of
activity levels and current symptoms, do not in this
study correlate with surgical outcomes. Patient satisfac-
tion may be best incorporated into a questionnaire using
the WOMET score, but again, this requires further re-
search and discussion with specific patient focus groups.
The BMLR analysis did not find any risk factors that were
significantly associated with failure, although gender (surgi-
cal and clinical failure) and number of concomitant proce-
dures (clinical failure) were nearly significant. However,
given the heterogeneity of concomitant procedures, future
studies could investigate the effect of these different proce-
dures on the success of MAT. The odds ratios showed that
except for lateral (vs medial) MAT in surgical failure, all
risk factors increased the odds of surgical or clinical failure.
However, many of these odds ratios were close to unity, re-
inforcing their lack of statistical significance.
This study’s analyses support the findings of Parkinson
et al. [13] and Ahn et al. [38] that potential risk factors of
age, gender and number of concomitant procedures were
not related to surgical failure. However, our study disagrees
with those studies, in that Outerbridge classification and
lateral vs medial were not found to be significant factors in
our analysis. Whilst some studies have found that articular
cartilage damage at the time of surgery and medial (vs. lat-
eral) allografts are associated with a higher risk of surgical
failure [13], this study supports the findings of other papers
that conclude that cartilage damage does not make a differ-
ence [38–40] and that medial allografts are not at a higher
risk of surgical failure [40]. Importantly, however, it should
be noted that where articular cartilage damage was found
in the relevant compartment of a patient’s knee at the time
of MAT surgery, the articular cartilage pathology was also
treated at the same time; with radiofrequency coblation
chondroplasty for unstable or rough partial thickness chon-
dral damage, with microfracture for small (<2cm2) full-
thickness defects or with articular cartilage grafting (using
Chondrotissue grafting) for larger (>2cm2) defects. There-
fore, it could be surmised that appropriate concomitant
treatment of articular cartilage lesions possibly lessens or
even eliminates the otherwise increased risk of failure after
MAT that might otherwise be associated with increasing
severity of articular cartilage damage.
One reason for the lack of significance found in some of
our analyses might be the small sample size in the present
study, combined with the number of risk factors examined,
which could have led to a lack of statistical power. The
methods in the present study were better controlled com-
pared to some previous research: only fresh-frozen meniscal
allografts (which are biologically and mechanically superior
to other forms of preservation [41]) were used, and these
were all sourced from a single provider, and a single one-
surgeon technique was used. Previous authors have either
not reported their allograft sources [38, 42] or have used
multiple providers with different preservation techniques
[13]. Additionally, the generally good outcomes following
MAT in the present study may be attributable to the surgi-
cal technique; suture fixation of the allograft to the capsule
combined with trans-tibial bone tunnel suture fixation is
the current preferred technique [14, 43, 44]. Techniques
using bone plug fixation risk articular cartilage damage and
have been associated with a higher failure rate [45, 46].
There was no difference in the SF-12 mental sub-scores
in patients who said that they would undergo surgery
again versus those who would not, although the physical
sub-score was approaching significance. Saltzman et al.
[47] and Rue et al. [48] also previously reported that the
physical component improved significantly following
MAT but that the mental score did not.
It was observed that following MAT, patients returned
to fewer and lower levels of sport. Seventeen patients
were satisfied with the level of sport achieved following
MAT, but 17 others were dissatisfied. Nearly 80% of pa-
tients did expect there to be a difference in the level of
physical activity that they could achieve after MAT, al-
though there were no differences between the satisfac-
tion levels between those who expected there to be a
difference and those who did not. It is unclear whether
the protective post-operative regime or the MAT pro-
cedure itself explains the dissatisfaction about not being
able to return to sport.
Limitations
The present study had a number of limitations. First, the
sample size was smaller than some comparable studies
[13, 38] and so statistical power will have been weak-
ened. However, this was offset by the tight control over
materials and methods, and by the use of one surgeon,
reducing variability in the procedures. Whilst this en-
sures homogeneity, longer-term studies are required to
ensure a sample size is large enough for an adequately
powered analysis for each failure sub-group analysis.
MAT is a relatively new procedure in the UK and sam-
ple sizes are currently small.
Second, there were no pre-operative PROMs available,
apart from the Tegner values. As this was a retrospective
study, the collection of pre-operative scores was not
feasible. However, this is not unusual, and other authors
[13, 38] have also used retrospective methods. As with
all retrospective studies, there will be significant recall
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bias. It is still possible to draw useful conclusions from
retrospective studies, but in future more prospective
PROMs should be taken prior to MAT surgery.
As there was no continual follow-up, clinical failure
may have occurred prior to the time at which the study
was performed. It was also not possible in this study to
review the potential risk factors of mechanical axis, in-
stability or BMI, as not enough information was avail-
able for this within the patient records, and therefore a
confounding effect in our results cannot be ruled out.
However, in the senior author’s practice it is standard
practice to correct any varus or valgus malignment
greater than 5o with an appropriate realignment osteot-
omy either in advance of or at the same time as MAT.
Conclusions
This retrospective study, with 3-year follow-up of 43 pa-
tients undergoing MAT, reported outcome scores that
are consistent with success, with scores of 82.1, 62.1 and
88 for KOOS, IKDC and Lysholm, respectively. Those
patients classified as clinical failures had significantly
lower outcome scores, although the four patients with
surgical failure did not, possibly due to the small sample.
It was not possible to identify significant pre-operative
risk factors associated with surgical or clinical failure, al-
though gender (being female) and the number of con-
comitant procedures were nearly significant and had
high odds ratios. The use of the terms ‘surgical failure’,
‘clinical failure’ and ‘patient satisfaction’ may need fur-
ther consideration, since up to 60% of patients defined
as clinical / surgical failures said that they would
undergo the procedure again. Either newer outcome
measures, such as the WOMET, or a bespoke MAT-
specific measure could help to re-define success / failure
and establish a more sensitive marker of graft survival
and the anticipated chondroprotective effects of MAT.
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